Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Carbohydrate ingestion results in a fall in glucagon concentration in non-diabetic but not in diabetic individuals. To determine if, and the mechanism by which, lack of postprandial suppression of glucagon contributes to hyperglycaemia, nine subjects with insulin-dependent diabetes mellitus (IDDM) ingested 50 g of glucose containing both [2-3H] glucose and [6-3H] glucose on two occasions. [6-14C] glucose, insulin and low-dose somatostatin were infused intravenously at the same rates on both occasions. A basal glucagon infusion was started either at the same time ("constant glucagon") or 2 h following ("suppressed glucagon") glucose ingestion. This resulted in lower (p < 0.001) glucagon concentrations during the first 2 h of the suppressed than during the constant glucagon study days (63 +/- 1 vs 108 +/- 2 pg/ml). Lack of suppression of glucagon led to higher (p < 0.01) postprandial glucose concentrations (10.3 +/- 0.9 vs 8.1 +/- 0.7 mmol/l) and a greater (p < 0.02) integrated glycaemic response. The excessive rise in glucose was due to higher (p < 0.02) rates of postprandial hepatic glucose release during the constant than during the suppressed glucagon study days, whether measured using either [6-3H] glucose (2.6 +/- 0.2 vs 2.0 +/- 0.2 mmol.kg-1 per 6 h) or [2-3H] glucose (3.0 +/- 0.3 vs 2.4 +/- 0.2 mmol.kg-1 per 6 h) as the meal tracer. Glucose disappearance, initial splanchnic glucose clearance and hepatic glucose cycling did not differ on the two occasions. Thus, the present studies demonstrate that lack of postprandial suppression of glucagon, by increasing hepatic glucose release, contributes to hyperglycaemia in subjects with IDDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have estimated that postprandial hyperglucagonemia may contribute to ~50% of the pathological increase in plasma glucose levels after glucose ingestion.145–147”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816 · cited 1×
“Glucose turnover was calculated using Steele's non-steady-state equations [20].”
MethodThe Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Futile Cycles in the Metabolism of Glucose
(1976) · Current Topics in Cellular Regulation · doi:10.1016/b978-0-12-152810-2.50013-9 · Cited by 321 · cited 2×
“Hepatic glucose cycling refers to the concomitant uptake and release of glucose by the liver [27].”
BackgroundMethodFirth, R. G., Bell, P. M., Marsh, H. M., Hansen, I., & Rizza, R. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112467 · Cited by 280
Self-citationHyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects
Sherwin, R. S., Fisher, M., Hendler, R., & Felig, P. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940901 · Cited by 252 · cited 2×
“Changes in portal venous insulin concentrations likely account for previous failures to detect an effect of glucagon on postprandial carbohydrate tolerance in non-diabetic volunteers '[7-9].”
BackgroundRole of glucagon in the pathogenesis of diabetes: The status of the controversy
Unger, R. H. (1978) · Metabolism · doi:10.1016/0026-0495(78)90291-3 · Cited by 216 · cited 6×
“This reciprocal relationship between glucose and gtucagon is abolished by diabetes mellitus [1, 2, 11].”
BackgroundInfluentialA simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol.
Eberts, T. J., Sample, R. H., Glick, M. R., & Ellis, G. H. (1979) · Clinical Chemistry · doi:10.1093/clinchem/25.8.1440 · Cited by 199 · cited 1×
“, USA) and D-xylose by a colorimetric assay [18].”
MethodCURRENT TOPICS IN CELLULAR REGULATION
Stadtman, E. R., & Chock, P. B. (1996) · Shock · doi:10.1097/00024382-199609010-00016 · Cited by 179
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Dinneen, S., Alzaid, A., Miles, J., & Rizza, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116832 · Cited by 175 · cited 4×
“In non-diabetic individuals glucagon concentrations fall as glucose concentrations rise, and rise as glucose concentrations return toward preprandial levels [12-14].”
BackgroundMethodInfluentialSelf-citationHormonal control of substrate cycling in humans.
Miyoshi, H., Shulman, G. I., Peters, E. J., Wolfe, M. H., Elahi, D., & Wolfe, R. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113487 · Cited by 139 · cited 4×
“Hyperglucagonaemia can increase glucose output by stimulating glycogenolysis, gluconeogenesis and/or glucose/glucose 6-phosphate cycling [3-5].”
BackgroundResultInfluentialButler, P. C., & Rizza, R. A. (1991) · Diabetes · doi:10.2337/diab.40.1.73 · Cited by 130 · cited 10×
“Initial splanchnic glucose clearance was calculated by subtracting the integrated appearance of ingested glucose over a 6-h period from the total amount of glucose ingested [13, 16].”
BackgroundMethodInfluentialSelf-citationBlackard, W. G., Nelson, N. C., & Andrews, S. S. (1974) · Diabetes · doi:10.2337/diab.23.3.199 · Cited by 125 · cited 1×
“In the few studies in which portal glucagon concentrations have been measured in humans, the data indicate a 50 % extraction of glucagon by the liver [30, 31].”
BackgroundPractical Closed-Loop Insulin Delivery
White, N. H., SKOR, D., & SANTIAGO, J. V. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-2-210 · Cited by 110
Bomboy, J. D., Lewis, S. B., LACY, W. W., SINCLAIR-SMITH, B. C., & LILJENQUIST, J. E. (1977) · Diabetes · doi:10.2337/diab.26.3.177 · Cited by 99 · cited 1×
“Previous studies have shown that stimulation of glycogenolysis by glucagon appears to be transient since hepatic glucose release returns toward baseline despite continued hyperglucagonaemia [22-24].”
BackgroundBell, P. M., Firth, R. G., & Rizza, R. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112739 · Cited by 97 · cited 2×
“As previously described, hepatic glucose cycling was calculated [13, 19] as the difference between the appearance of [2-3H] glucose (a tracer which is detritiated”
BackgroundMethodSelf-citationEffects of Somatostatin on Gastrointestinal Propagation and Absorption of Oral Glucose in Man
Johansson, C., Wisén, O., Efendić, S., & Uvnäs‐Wallensten, K. (2009) · Digestion · doi:10.1159/000198619 · Cited by 95 · cited 2×
“Consistent with previous reports [34], we established in pilot studies that the dose of somatostatin can be titrated so that when infused in small amounts (i.”
BackgroundResultSimilar Dose Responsiveness of Hepatic Glycogenolysis and Gluconeogenesis to Glucagon In Vivo
Stevenson, R. W., Steiner, K., Davis, M. A., Hendrick, G. K., Williams, P. E., LACY, W. W., Brown, L. L., Donahue, P., Lacy, D. B., & Cherrington, A. D. (1987) · Diabetes · doi:10.2337/diab.36.3.382 · Cited by 83 · cited 3×
“Hyperglucagonaemia can increase glucose output by stimulating glycogenolysis, gluconeogenesis and/or glucose/glucose 6-phosphate cycling [3-5].”
BackgroundResultGlucagon and diabetes: A reappraisal
Lefèbvre, P. J., & LUYCKX, A. S. (1979) · Diabetologia · doi:10.1007/bf01223153 · Cited by 77 · cited 6×
“This reciprocal relationship between glucose and gtucagon is abolished by diabetes mellitus [1, 2, 11].”
BackgroundInfluentialPostprandial Hyperglycemia in Patients with Noninsulin-dependent Diabetes Mellitus
Firth, R. G., Bell, P. M., Marsh, H. W., & RIZZA, R. A. (1986) · Cited by 75
Self-citationGerich, J. E., Tsalikian, E., Lorenzi, M., Schneider, V. B., Bohannon, N. V., Gustafson, G. M., & Karam, J. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-6-1178 · Cited by 74 · cited 2×
“While acute increases in glucagon can increase glucose [3-5], fasting glucagon concentrations in subjects with IDDM are only slightly higher than those present in non-diabetic subjects and increase minimally if at all following carbohydrate ingestion [1, 2, 10, 11].”
BackgroundIncreased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes.
Efendić, S., Wajngot, A., & Vranić, M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.2965 · Cited by 71 · cited 1×
“Increased cycling also has been observed in subjects with non-insulin-dependent diabetes during intravenous glucose infusion or following food ingestion [13, 29].”
BackgroundTse, T. F., Clutter, W. E., Shah, S. D., Miller, J. P., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110966 · Cited by 68 · cited 3×
“In non-diabetic individuals glucagon concentrations fall as glucose concentrations rise, and rise as glucose concentrations return toward preprandial levels [12-14].”
BackgroundRizza, R., Verdonk, C., Miles, J., Service, F. J., & Gerich, J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109404 · Cited by 68
Self-citationJaspan, J. B., Polonsky, K. S., Lewis, M., Pensler, J., Pugh, W., Moossa, A. R., & Rubenstein, A. H. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.3.e233 · Cited by 68 · cited 1×
“Since somatostatin inhibits the secretion of the 3500 molecular weight species of glucagon [32] its effect is seen first in the portal circulation, implying that the decrement in postprandial portal glucagon concentration must b e - 40 pg/ml.”
BackgroundRaskin, P., & Unger, R. H. (1978) · Diabetes · doi:10.2337/diab.27.4.411 · Cited by 54 · cited 2×
“While acute increases in glucagon can increase glucose [3-5], fasting glucagon concentrations in subjects with IDDM are only slightly higher than those present in non-diabetic subjects and increase minimally if at all following carbohydrate ingestion [1, 2, 10, 11].”
BackgroundPERSISTENT EFFECT OF SUSTAINED HYPERGLUCAGONEMIA ON GLUCOSE PRODUCTION IN MAN
Rizza, R. A., & Gerich, J. E. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-2-352 · Cited by 49 · cited 1×
“However, a persistent glucagon effect is evinced by a rise or fall in glucose release when plasma glucagon concentration is either increased or decreased [25, 26].”
BackgroundSelf-citationFRADKIN, J. E., Shamoon, H., Felig, P., & Sherwin, R. S. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-698 · Cited by 43
Testing of the assumptions made in estimating the extent of futile cycling
Wajngot, A., Chandramouli, V., Schumann, W. C., Kumaran, K., Efendić, S., & Landau, B. R. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.5.e668 · Cited by 39 · cited 1×
“cussed in detail elsewhere, this approach provides a reasonable but not perfect estimate of cycling [28].”
BackgroundEffects of pulsatile delivery of insulin and glucagon in humans
Paolisso, G., Scheen, A. J., Albert, A., & Lefebvre, P. J. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.5.e686 · Cited by 37 · cited 1×
“To the extent that pulsatile glucagon administration has a greater biologic effect than constant [33] we may have underestimated the difference in glycaemia that would have been observed in the presence and absence of postprandial suppression of glucagon.”
BackgroundCherrington, A. D., Diamond, M. P., Green, D. R., & Williams, P. E. (1982) · Diabetes · doi:10.2337/diab.31.10.917 · Cited by 35 · cited 1×
“Previous studies have shown that stimulation of glycogenolysis by glucagon appears to be transient since hepatic glucose release returns toward baseline despite continued hyperglucagonaemia [22-24].”
BackgroundTranshepatic Glucagon Gradients in Man: Evidence for Glucagon Extraction by Human Liver*
Jaspan, J. B., Rudick, J., & Rayfield, E. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-2-287 · Cited by 31 · cited 1×
“In the few studies in which portal glucagon concentrations have been measured in humans, the data indicate a 50 % extraction of glucagon by the liver [30, 31].”
BackgroundButler, P. C., & Rizza, R. A. (1991) · Diabetes · doi:10.2337/diabetes.40.1.73 · Cited by 29
Self-citationThe Control of Glycogen Metabolism in the Liver
Hers, H. G., Stalmans, W., WULF, H. D., Laloux, M., & Hue, L. (1974) · Springer eBooks · doi:10.1007/978-3-642-80817-3_9 · Cited by 26
Katz, H., Homan, M., Jensen, M., Caumo, A., Cobelli, C., & Rizza, R. A. (1994) · Diabetes · doi:10.2337/diab.43.2.289 · Cited by 24 · cited 2×
“However, in order to render the diabetic volunteers modestly insulin-deficient during the postprandial period, the amount of insulin given during the postprandial infusion equaled only 75 % of the non-diabetic profile [17].”
BackgroundMethodSelf-citationHolst, J. J., Madsen, O. G., Knop, J., & Schmidt, A. (1977) · Diabetologia · doi:10.1007/bf01234501 · Cited by 23 · cited 2×
“Changes in portal venous insulin concentrations likely account for previous failures to detect an effect of glucagon on postprandial carbohydrate tolerance in non-diabetic volunteers '[7-9].”
BackgroundLack of a Role for Glucagon in the Disposal of an Oral Glucose Load in Normal Man*
LILJENQUIST, J. E., & Rabin, D. D. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-6-937 · Cited by 21 · cited 2×
“Changes in portal venous insulin concentrations likely account for previous failures to detect an effect of glucagon on postprandial carbohydrate tolerance in non-diabetic volunteers '[7-9].”
BackgroundGlucagon-stimulated glycogenolysis: time-dependent sensitivity to insulin.
El-Refai, M. F., & Bergman, R. N. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.3.e246 · Cited by 13 · cited 1×
“Previous studies have shown that stimulation of glycogenolysis by glucagon appears to be transient since hepatic glucose release returns toward baseline despite continued hyperglucagonaemia [22-24].”
BackgroundImportance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs
Lickley, H. L. A., Kemmer, F. W., El-Tayeb, K. M. A., & Vranić, M. (1987) · Diabetologia · doi:10.1007/bf00274224 · Cited by 12 · cited 4×
“Hyperglucagonaemia can increase glucose output by stimulating glycogenolysis, gluconeogenesis and/or glucose/glucose 6-phosphate cycling [3-5].”
BackgroundResultInfluentialKatz, H., Homan, M., Jensen, M., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.2.289 · Cited by 6
Cited by
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
“A lack of suppression of hyperglucagonemia has also been shown to contribute to postprandial glucose intolerance in type 1 diabetes (26).”
BackgroundBonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670
Gerich, J. E., Meyer, C., Woerle, H. J., & Stumvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 606
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Glucose Metabolism and Regulation: Beyond Insulin and Glucagon
Aronoff, S. L., Berkowitz, K., Shreiner, B., & Want, L. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.3.183 · Cited by 569
Metadata
- Authors
- Dinneen, S., Alzaid, A., Turk, D., & Rizza, R.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Dinneen, S.
- Venue
- Diabetologia
- Published
- 1995-03
- Volume
- 38
- Issue
- 3
- Pages
- 337-343
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2068377236
- Cited by
- 190
- References
- 38
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 13 · 2020: 8 · 2019: 3 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 11 · 2013: 5 · 2012: 7
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Mayo Foundation for Medical Education and Research
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 29953)
- National Center for Research Resources (RR-00585, M01RR000585)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucagon suppression, postprandial hyperglycemia, type 1 diabetes, hepatic glucose production, glucagon, glucose ingestion, somatostatin, glucose clearance
- MeSH terms
- Adult, Blood Glucose, Carbon Radioisotopes, Diabetes Mellitus, Type 1, Dietary Carbohydrates, Eating, Female, Glucagon, Glucose, Humans, Hyperglycemia, Infusions, Intravenous, Insulin, Kinetics, Liver, Male, Portal System, Radioisotope Dilution Technique, Somatostatin, Time Factors, Tritium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.